Navigation Links
Media Alert From Residual Risk Reduction Initiative (R3i): 19:00 CST Sunday 9 November 2008

NEW ORLEANS, Louisiana, November 7 /PRNewswire/ --

- Residual Vascular Risk Reduction: The Global Call to Action

- Announcement of the Launch of the Residual Risk Reduction Initiative: R3i


Residual Risk Reduction Initiative (R3i) calls for action to reduce the lipid related residual vascular risk unaddressed by current standards of care in millions of patients with heart disease and diabetes

Audubon Room, Ritz Carlton Hotel, 921 Canal Street, New Orleans, USA


Sunday 9 November 2008, 19:00-20:30 hrs CST (GMT- 6hrs)

WHAT: Internationally recognized specialists from North America, Europe, Asia and Japan come together to launch the Residual Risk Reduction Initiative (R3i) - a unique global program to evaluate and to reduce the excess risk of myocardial infarction, stroke, kidney disease, loss of vision and non-traumatic limb amputation which exists in many patients with heart disease and diabetes despite optimal, currently available care.

To address these important issues, the R3i engages healthcare professionals in an innovative global initiative of academic research, education and advocacy.


Professor Frank Sacks, Vice-President R3i, Department of Nutrition Harvard School of Public Medicine, Boston, MA, USA

Professor W.Virgil Brown, International Steering Committee R3i, Charles Howard Candler Professor of Medicine, Emory University, Chief of Medicine, Atlanta, GA, USA

Professor Michel Hermans, General Secretary R3i, Department of Endocrinology and Nutrition, Cliniques Universitaires St. Luc, Université Catholique de Louvain, Brussels, Belgium

SOURCE Residual Risk Reduction Initiative (R3i)
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Media Advisory - Oncolytics Biotech Inc. to Present at Rodman & Renshaw 10th Annual Healthcare Conference
2. BioLife Solutions Submits FDA Master File on HypoThermosol(R) Preservation and Storage Media for Cells, Tissues
3. Progress toward new storage media
4. Edmonton's Technology Community: Using Social Media to Raise Awareness
5. Katrina Proven Certified Organic Toxic Mold Remedy Now Available for Mold Remediation Professionals and Homeowners
6. Media Advisory - Oncolytics Biotech Inc. to Present at BIO Investor Forum 2008
7. Six Sigma and Social Media: Tools for Reducing Costs, Improving Processes
8. Media Advisory - Oncolytics Biotech Inc. to Present at BioPartnering Europe
9. Media Advisory - Oncolytics Biotech Inc. to Present at Maxim Group Growth Conference
10. Cell Therapeutics Provides Details on Investor & Media Day to be Held in Milan, Italy on Friday, October 3, 2008
11. Huifeng Bio-pharmaceutical Technology Inc. Announces Strategic Alliance with Premier Media Service Inc.
Post Your Comments:
(Date:11/27/2015)... 2015 --> ... companion diagnostics is one of the major ... pharmaceutical companies and diagnostic manufacturers working together ... . --> ... global cancer biomarkers market spread across 89 ...
(Date:11/25/2015)...  PharmAthene, Inc. (NYSE MKT: PIP) announced  today that ... plan (Rights Plan) in an effort to preserve the ... Section 382 of the Internal Revenue Code (Code). ... of its NOLs could be substantially limited if the ... 382 of the Code. In general, an ownership change ...
(Date:11/25/2015)... Nov. 25, 2015  Neurocrine Biosciences, Inc. (Nasdaq: ... President and CEO of Neurocrine Biosciences, will be presenting ... New York . ... website approximately 5 minutes prior to the presentation to ... the presentation will be available on the website approximately ...
(Date:11/25/2015)... November 25, 2015 The ... is a professional and in-depth study on the ...      (Logo: ) , ... industry including definitions, classifications, applications and industry chain ... the international markets including development trends, competitive landscape ...
Breaking Biology Technology:
(Date:11/16/2015)... Calif. , Nov 16, 2015  Synaptics ... of human interface solutions, today announced expansion of ... TouchView ™ touch controller and display driver ... revolution of smartphones. These new TDDI products add ... TD4100 (HD resolution), TD4302 (WQHD resolution), and TD4322 ...
(Date:11/10/2015)... , Nov. 10, 2015  In this ... the basis of product, type, application, disease ... in this report are consumables, services, software. ... are safety biomarkers, efficacy biomarkers, and validation ... report are diagnostics development, drug discovery and ...
(Date:11/2/2015)... , Nov. 2, 2015  SRI International has ... to provide preclinical development services to the National Cancer ... SRI will provide scientific expertise, modern testing and support ... of preclinical pharmacology and toxicology studies to evaluate potential ... --> The PREVENT Cancer Drug Development Program is ...
Breaking Biology News(10 mins):